Features | Partner Sites | Information | LinkXpress
Sign In
PURITAN MEDICAL
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Antitoxin Vaccine Protects Laboratory Animals Against Staphylococcus Infection

By BiotechDaily International staff writers
Posted on 31 Dec 2013
Image: Scanning electron micrograph (SEM) showing numerous clumps of methicillin-resistant Staphylococcus aureus (MRSA) magnified 4,780x (Photo courtesy of the CDC - Centers for Disease Control and Prevention).
Image: Scanning electron micrograph (SEM) showing numerous clumps of methicillin-resistant Staphylococcus aureus (MRSA) magnified 4,780x (Photo courtesy of the CDC - Centers for Disease Control and Prevention).
A vaccine comprising a cocktail of superantigens and cytolysins protected rabbits challenged with virulent strains of Staphylococcus aureus while vaccines based on bacterial surface antigens failed to protect the animals or actually increased the severity of the infection.

Superantigens (SAgs) are a class of antigens that cause nonspecific activation of T-cells resulting in polyclonal T-cell activation and massive cytokine release. SAgs are produced by pathogenic microbes (including viruses, mycoplasma, and bacteria) as a defense mechanism against the immune system. Compared to a normal antigen-induced T-cell response where 0.0001–0.001% of the body’s T-cells are activated, SAgs are capable of activating up to 25% of the body’s T-cells.

Previous attempts to vaccinate laboratory animals with bacterial cell-surface proteins failed to protect them and, in some cases, actually increased the severity of the infection.

Using a different approach, investigators at the University of Iowa (Iowa City, USA) vaccinated rabbits with a cocktail of wild-type toxins or toxoids produced and secreted by S. aureus, which was made up of combinations of superantigens (toxic shock syndrome toxin-1, enterotoxins B and C, and enterotoxin-like X) and cytolysins (alpha, beta, and gamma-toxins). Other rabbits were passively vaccinated with hyperimmune serum taken from some of the actively vaccinated animals. The rabbits were challenged with multiple strains of S. aureus, both methicillin-sensitive and methicillin-resistant (MRSA).

Results published in the December 19, 2013, online edition of the Journal of Infectious Disease revealed that vaccination against secreted superantigens and cytolysins resulted in protection of 86/88 rabbits when challenged intrapulmonary with nine different S. aureus strains, compared to only 1/88 nonvaccinated animals.

Not only did the vaccine protect the animals from dying but also seven days after vaccination pathogenic bacteria could not be detected in the animals' lungs.

Passive immunization studies demonstrated that production of neutralizing antibodies was critically involved in the protective mechanism.

"Our study suggests that vaccination against these toxins may provide protection against all strains of Staphylococcus," said senior author Dr. Patrick Schlievert, professor of microbiology at the University of Iowa. "If we can translate this finding into an effective vaccine for people it could potentially prevent millions of cases of serious and milder skin and soft tissue infections yearly."

Related Links:

University of Iowa



Channels

Drug Discovery

view channel
Image: A new micelle delivery system for the protective polyphenols resveratrol and quercetin (mRQ) may have value in cancer chemotherapy (Photo courtesy of Oregon State University).

Micelles Containing Resveratrol and Quercetin Reverse Doxorubicin Cardiotoxicity

Cancer researchers blocked the toxic effects of the cancer drug doxorubicin (DOX) by administering it together with the plant antioxidants resveratrol and quercetin. Although in use for more than 40... Read more

Lab Technologies

view channel
Image: The Leica DM2500 LED Microscope for clinical laboratories and research applications (Photo courtesy of Leica Microsystems).

New LED Microscope Completes Line of Clinical and Research Tools

A popular microscope used for both clinical and research applications is now available with LED illumination. The Leica (Wetzlar, Germany) DM2500 and DM2500 LED microscopes represent a class of tools... Read more

Business

view channel

Teva Buys Allergan Generic Business Unit

Teva Pharmaceutical Industries (Petah Tikva, Israel) has bought the Allergan (Irvine, CA, USA) generic drugs business for USD 40.5 billion in cash and stock, solidifying its position as the world's largest generic drug maker. Under the terms of the agreement, Teva will pay USD 33.75 billion in cash and USD 6.... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.